首页> 外文OA文献 >A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer

【2h】

A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer

机译：A II期研究评估Sunitinib苹果酸的安全性和功效与每周紫杉醇组合，然后是多柔比星和每日口服环磷酰胺加G-CSF作为局部晚期或炎症乳腺癌的Neoadjuvant化疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Lynn Symonds; Isaac Jenkins; Hannah M Linden; Brenda Kurland; Julie R Gralow; Vijayakrishna (V.K.) Gadi; Georgiana K Ellis; Qian Wu; Eve Rodler; Pavani Chalasani; Xiaoyu Chai; Jinny Riedel; Alison Stopeck; Ursa Brown-Glaberman; Jennifer M Specht;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 来自一项艾日布林联合吉西他滨对比紫杉醇联合吉西他滨作为HER2阴性转移性乳腺癌的一线化疗的II期、多中心、随机试验的包含神经病变相关量表的生活质量结果:韩国癌症研究组试验(KCSG BR13-11) [J] . Ji-Yeon Kim, Young-Hyuck Im, Tae-Yong Kim, 癌症（英文版） . 2019,第008期
2. Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0012 [J] . EllisG.K., BarlowW.E., GralowJ.R., Journal of Clinical Oncology . 2011,第8期

机译：标准阿霉素和环磷酰胺与每周阿霉素和每日口服环磷酰胺加粒细胞集落刺激因子作为炎性和局部晚期乳腺癌新辅助治疗的III期比较：SWOG 0012
3. Efficacy and Safety of Neoadjuvant Treatment with Bevacizumab, Liposomal Doxorubicin, Cyclophosphamide and Paclitaxel Combination in Locally/Regionally Advanced, HER2-Negative, Grade III at Premenopausal Status Breast Cancer: A Phase II Study [J] . Tampaki Ekaterini C., Tampakis Athanasios, Alifieris Constantinos E., Clinical drug investigation . 2018,第7期

机译：Neoadjuvant治疗用贝伐单抗，脂质体Doxorubicin，环磷酰胺和紫杉醇组合在局部/地区先进，HER2阴性，III级乳腺癌中的疗效和安全性：II期研究
4. Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9 [J] . Abraham Jame, Robidoux Andr, Tan Antoinette R., Breast cancer research and treatment. . 2015,第2期

机译：NSABP基金会研究FB-9，评估II期随机临床试验，评估每周辅助用紫杉醇或艾瑞布林联合阿霉素和环磷酰胺的新辅助化疗方案对局部晚期HER2阴性乳腺癌妇女的作用
5. Phase I/II clinical trials on the effect of weekly paclitaxel (wPTX) and wPTX containing combination regimens for advanced and metastatic gastric cancer -ECRIN group studies [C] . Sakamoto J, Kodera Y, Kobayashi M, International Gastric Cancer Congress . 2009

机译：I / II期临床试验关于每周紫杉醇（WPTX）和WPTX含有晚期和转移性胃癌组合方案的临床试验 - 分泌组研究
6. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
7. Phase III Comparison of Standard Doxorubicin and Cyclophosphamide Versus Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor As Neoadjuvant Therapy for Inflammatory and Locally Advanced Breast Cancer: SWOG 0012 [O] . Georgiana K. Ellis, William E. Barlow, Julie R. Gralow, -1

机译：标准阿霉素和环磷酰胺与每周阿霉素和每日口服环磷酰胺加粒细胞集落刺激因子作为炎性和局部晚期乳腺癌的新辅助治疗的第三阶段比较：SWOG 0012
8. Phase III Comparison of Standard Doxorubicin and Cyclophosphamide Versus Weekly Doxorubicin and Daily Oral Cyclophosphamide Plus Granulocyte Colony-Stimulating Factor As Neoadjuvant Therapy for Inflammatory and Locally Advanced Breast Cancer: SWOG 0012 [O] . Ellis, Georgiana K., Barlow, William E., Gralow, Julie R., 2011

机译：标准阿霉素和环磷酰胺与每周阿霉素和每日口服环磷酰胺加粒细胞集落刺激因子作为炎性和局部晚期乳腺癌的新辅助治疗的第三阶段比较：SWOG 0012

A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination With Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer

著录项

相似文献

相关主题

期刊订阅